{
    "clinical_study": {
        "@rank": "23411", 
        "acronym": "ERAS", 
        "arm_group": [
            {
                "arm_group_label": "ERAS perioperative cares", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients planned to undergoing laparoscopic gastrectomy, following the ERAS protocols."
            }, 
            {
                "arm_group_label": "Conventional perioperative cares", 
                "arm_group_type": "Active Comparator", 
                "description": "Patents will be managed by our hospital's critical pathways."
            }
        ], 
        "brief_summary": {
            "textblock": "Enhanced Recovery After Surgery (ERAS) programs have been introduced with purposes of\n      reducing the surgical stress response and obtaining optimal recovery after surgery."
        }, 
        "brief_title": "Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastric Cancer", 
        "condition_browse": {
            "mesh_term": "Stomach Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "There is strong evidence of the usefulness of the ERAS programs in patients undergoing\n      colorectal surgery in terms of significantly reduced postoperative complications and shorter\n      length of hospital stay, compared to the patients of conventional treatment.\n\n      However, few studies exist about the implication of ERAS programs in the laparoscopic\n      gastrectomy.\n\n      The aim of this study was to compare the recovery rate, morbidity, and quality of life in\n      the patients undergoing laparoscopic gastrectomy for gastric cancer,  receiving either ERAS\n      protocol or conventional postoperative cares."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Elective surgery\n\n          -  American Society of Anesthesiologists (ASA) scores < 3\n\n          -  20 < Age < 80\n\n          -  Gastric cancer, adenocarcinoma, possible to perform laparoscopic distal gastrectomy\n\n          -  Informed consent\n\n          -  No other treatment (Radiation, Chemotherapy or Immunotherapy) on this gastric cancer\n             or other type of cancer.\n\n          -  No systemic inflammatory disease\n\n        Exclusion Criteria:\n\n          -  Emergency operation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01938313", 
            "org_study_id": "SNUBH-ERAS-GC-PII"
        }, 
        "intervention": [
            {
                "arm_group_label": "ERAS perioperative cares", 
                "description": "Patient's preoperative counseling & education before surgery\nNo Bowel preparation\nOral Carbohydrate Solution (OCS) loading until 2hours before surgery\nFluid restriction & Management by pulse contour analysis or transesophageal doppler\nEarly mobilization\nEarly oral feeding (postoperative 1 day - sips of water, 2 days - semifluid diet (SFD), 3 days - soft blended diet (SBD))\nEpidural patient controlled analgesics (no opioids analgesics)\nPostoperative Nausea Active Control\nThromboembolism prophylaxis by low molecular weighted heparin (LMWH)\nPerioperative High content Oxygen therapy\nNo drain insertion\nNo Levin tube\nPatients will be discharged at POD#4 if there's no problem.", 
                "intervention_name": "ERAS perioperative cares", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Conventional perioperative cares", 
                "description": "No Patient's preoperative counseling & education before surgery\nBowel preparation\nNo Oral Carbohydrate Solution (OCS) loading until 2hours before surgery\nConventional Fluid Management by clinical signs (Urine output, heart rate etc.)\nConventional Mobilization\nConventional oral feeding (POD#2 SOW, #3 SFD, #4 SBD)\nIV PCA\nPostoperative Nausea Control if needed\nNo Thromboembolism prophylaxis\nNo or Low Content Oxygen therapy\nRoutine drain insertion\nLevin tube insertion if needed", 
                "intervention_name": "Conventional perioperative cares", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "gastric cancer", 
            "ERAS (early recovery after surgery)", 
            "fast track", 
            "laparoscopic gastrectomy"
        ], 
        "lastchanged_date": "September 4, 2013", 
        "location": {
            "contact": {
                "email": "viscaria@snubh.org", 
                "last_name": "Sang-Hoon Ahn, M.D.", 
                "phone": "+82-31-787-7099"
            }, 
            "facility": {
                "address": {
                    "city": "Seongnam", 
                    "country": "Korea, Republic of", 
                    "state": "Geynggi"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of ERAS (Early Recovery After Surgery) Protocol With Conventional Protocol After Laparoscopic Gastrectomy: A Prospective Randomized Controlled Trial (Phase II Study))", 
        "overall_contact": {
            "email": "hhkim@snubh.org", 
            "last_name": "Hyung-Ho Kim, M.D., Ph.D.", 
            "phone": "+82-31-787-7097"
        }, 
        "overall_contact_backup": {
            "email": "viscaria@snubh.org", 
            "last_name": "Sang-Hoon Ahn, M.D.", 
            "phone": "+82-31-787-7099"
        }, 
        "overall_official": {
            "affiliation": "Department of Surgery, SNUBH", 
            "last_name": "Hyung-Ho Kim, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Tolerance of diet for 24 hours A. Able to eat one third of more of soft-blend meal without abdominal discomfort, bloating, nausea, or vomiting\nAnalgesic-free (oral or IV analgesic drugs not necessary after cessation of PCA)\nSafe ambulation (ambulation of 600m without assistance)\nAfebrile status without major complications (fever defined as body temperature greater than 37.5)\nAbove total 4 criteria should be satisfied for the evaluation of complete recovery.", 
            "measure": "Recovering Rate", 
            "safety_issue": "Yes", 
            "time_frame": "4 days after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01938313"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Bundang Hospital", 
            "investigator_full_name": "Hyung-Ho Kim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Postoperative length of hospital stay", 
                "safety_issue": "Yes", 
                "time_frame": "up to 4 weeks after surgery"
            }, 
            {
                "measure": "Time to tolerance of a full diet", 
                "safety_issue": "No", 
                "time_frame": "up to 1 month after surgery"
            }, 
            {
                "measure": "Time to first bowel motion Time to first bowel motion", 
                "safety_issue": "No", 
                "time_frame": "up to 7 days after surgery"
            }, 
            {
                "measure": "Complications during the admissionTime to first bowel motion", 
                "safety_issue": "Yes", 
                "time_frame": "up to 30 days after surgery"
            }, 
            {
                "measure": "Readmission rate", 
                "safety_issue": "Yes", 
                "time_frame": "up to 30 days after surgery"
            }, 
            {
                "description": "postoperative 2hours, 6 hours, 1 days, 2 days, 3 days", 
                "measure": "Pain scores based on a visual analog scale the day of surgery and the subsequent 3 days", 
                "safety_issue": "No", 
                "time_frame": "up to 3 days after surgery"
            }, 
            {
                "description": "European organization for research and treatment of cancer (EORTC) and gastrointestinal quality of life index (GIQLI) questionnaire on postoperative 5 days, 1 month", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "up to 1 month after surgery"
            }
        ], 
        "source": "Seoul National University Bundang Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Bundang Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}